Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Journal of the Royal Society of Medicine
|
January 24, 2016
Jerome Cornfield's Bayesian approach to assessing interim results in clinical trials
James J Schlesselman
Preventive Medicine
|
September 26, 2006
The emerging case-control study: lung cancer in relation to tobacco smoking
James J Schlesselman
Obstetrics and Gynecology Clinics of North America
|
October 2, 2002
Perimenopausal use of reproductive hormones effects on breast and endometrial cancer
John A Collins, James J Schlesselman
Cancer Investigation
|
June 17, 2006
Phase II clinical trials in oncology: strengths and limitations of two-stage designs
James J Schlesselman, Isildinha M Reis
Seminars in Reproductive Medicine
|
June 14, 2003
Evaluating systematic reviews and meta-analyses
James J Schlesselman, John A Collins
American Journal of Obstetrics and Gynecology
|
April 24, 2004
Safety concerns and health benefits associated with oral contraception
Ronald Burkman, James J Schlesselman, Miriam Zieman
American Journal of Obstetrics and Gynecology
|
January 26, 2002
Family history of cancer, oral contraceptive use, and ovarian cancer risk
Gail R Walker, James J Schlesselman, Roberta B Ness
Oncology Reports
|
August 4, 2004
Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease
Rakesh Singal, Larry Ferdinand, Isildinha M Reis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2002
Risk of positive margins and biochemical recurrence in relation to nerve-sparing radical prostatectomy
Mario Sofer, Kara L Hamilton-Nelson, James J Schlesselman, et al.
International Journal of Oncology
|
October 20, 2004
Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk
Rakesh Singal, Larry Ferdinand, Partha M Das, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Journal of the Royal Society of Medicine
|
January 24, 2016
Jerome Cornfield's Bayesian approach to assessing interim results in clinical trials
James J Schlesselman
Preventive Medicine
|
September 26, 2006
The emerging case-control study: lung cancer in relation to tobacco smoking
James J Schlesselman
Obstetrics and Gynecology Clinics of North America
|
October 2, 2002
Perimenopausal use of reproductive hormones effects on breast and endometrial cancer
John A Collins, James J Schlesselman
Cancer Investigation
|
June 17, 2006
Phase II clinical trials in oncology: strengths and limitations of two-stage designs
James J Schlesselman, Isildinha M Reis
Seminars in Reproductive Medicine
|
June 14, 2003
Evaluating systematic reviews and meta-analyses
James J Schlesselman, John A Collins
American Journal of Obstetrics and Gynecology
|
April 24, 2004
Safety concerns and health benefits associated with oral contraception
Ronald Burkman, James J Schlesselman, Miriam Zieman
American Journal of Obstetrics and Gynecology
|
January 26, 2002
Family history of cancer, oral contraceptive use, and ovarian cancer risk
Gail R Walker, James J Schlesselman, Roberta B Ness
Oncology Reports
|
August 4, 2004
Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease
Rakesh Singal, Larry Ferdinand, Isildinha M Reis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2002
Risk of positive margins and biochemical recurrence in relation to nerve-sparing radical prostatectomy
Mario Sofer, Kara L Hamilton-Nelson, James J Schlesselman, et al.
International Journal of Oncology
|
October 20, 2004
Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk
Rakesh Singal, Larry Ferdinand, Partha M Das, et al.
Page
of 3